Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928095 · ClinicalTrials.gov registry record
RNA Cloning and Visualization in Human Atherosclerosis
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 22
- Enrollment target
NCT01928095 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 22 participants.
The verdict
NCT01928095 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The research objectives of this project are as follows: 1. Obtain high-quality human atherosclerotic arterial samples from diseased donors. 2. Perform biochemical analysis to determine the abundance, localization and activity of Dicer and double-stranded RNAs in these diseased tissues.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01928095
The ClinicalTrials.gov registry entry for NCT01928095 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01928095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01928095 about?
NCT01928095 is a clinical study titled "RNA Cloning and Visualization in Human Atherosclerosis". The research objectives of this project are as follows: 1. Obtain high-quality human atherosclerotic arterial samples from diseased donors. 2. Perform biochemical analysis to determine the abundance, localization and activity of Dicer and double-stranded RNAs in these diseased tissues.
What is the current status of trial NCT01928095?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2013-10. Estimated completion is 2016-11.
Who is sponsoring clinical trial NCT01928095?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.